Dr. Amit Gupta, MD, FACS, Ophthalmologist, talks about what to expect after having laser eye treatment for diabetic retinopathy.
GLP-1 receptor agonists were associated with better graft and patient survival. Clinical trials are needed to confirm these findings.
Semaglutide use in patients with type 2 diabetes moderately increases the risk of nonarteritic anterior ischemic optic neuropathy.